| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 146, 888-902, Copyright © 1995 by American Society for Investigative Pathology
REGULAR ARTICLES |
DL Greiner, LD Shultz, J Yates, MC Appel, G Perdrizet, RM Hesselton, I Schweitzer, WG Beamer, KL Shultz and SC Pelsue
Department of Medicine, University of Massachusetts, Worcester, USA.
T and B lymphocyte-deficient mice homozygous for the severe combined immunodeficiency (SCID) mutation can be immunologically engrafted with human lymphocytes. However, low levels of human peripheral blood mononuclear cell engraftment are commonly observed, impeding full use of this model. We now demonstrate that strain background in mice homozygous for the scid mutation is a strong determinant of levels of human lymphocyte engraftment. NOD/LtSz-scid/scid mice support higher levels of engraftment of both human spleen and peripheral blood mononuclear cells than do C.B-17-scid/scid mice. We observed, using human spleen cell injected scid mice, 1), high levels of engraftment of the host peripheral lymphoid tissues with human CD45+ (leukocytes), CD3+ (T cells), CD4+ (helper/inducer), and CD8+ (suppressor/cytotoxic) lymphoid cells for up to 24 weeks in NOD/LtSz-scid/scid mice; 2), migration of high numbers of human lymphocytes to peripheral lymphoid and nonlymphoid organs in NOD/LtSz-scid/scid, but not in C.B-17- scid/scid mice; 3), higher levels of serum immunoglobulin of human origin in NOD/LtSz-scid/scid mice than in C.B-17-scid/scid mice; 4), histological lesions characteristic of human anti-mouse xenoreactivity in NOD/LtSz-scid/scid mice; and 5), human origin antibodies against filarial antigens after engraftment with native human spleen cells. The use of NOD/LtSz-scid/scid mice as recipients to achieve significantly enhanced human lymphopoietic cell engraftment will now enable human immunity to be more easily studied in animal models.
This article has been cited by other articles:
 |
|
 |
|
  L. J. Giassi, T. Pearson, L. D. Shultz, J. Laning, K. Biber, M. Kraus, B. A. Woda, M. R. Schmidt, R. T. Woodland, A. A. Rossini, et al. Expanded CD34+ Human Umbilical Cord Blood Cells Generate Multiple Lymphohematopoietic Lineages in NOD-scid IL2r{gamma}null Mice Experimental Biology and Medicine, August 1, 2008; 233(8): 997 - 1012. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Tian, P. S. Woll, J. K. Morris, J. L. Linehan, and D. S. Kaufman Hematopoietic Engraftment of Human Embryonic Stem Cell-Derived Cells Is Regulated by Recipient Innate Immunity Stem Cells, May 1, 2006; 24(5): 1370 - 1380. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Sun, H. Wei, R. Sun, W. Xiao, Y. Yang, and Z. Tian Human Interleukin-15 Improves Engraftment of Human T Cells in NOD-SCID Mice Clin. Vaccine Immunol., February 1, 2006; 13(2): 227 - 234. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Ishikawa, M. Yasukawa, B. Lyons, S. Yoshida, T. Miyamoto, G. Yoshimoto, T. Watanabe, K. Akashi, L. D. Shultz, and M. Harada Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chainnull mice Blood, September 1, 2005; 106(5): 1565 - 1573. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Gorantla, K. Santos, V. Meyer, S. Dewhurst, W. J. Bowers, H. J. Federoff, H. E. Gendelman, and L. Poluektova Human Dendritic Cells Transduced with Herpes Simplex Virus Amplicons Encoding Human Immunodeficiency Virus Type 1 (HIV-1) gp120 Elicit Adaptive Immune Responses from Human Cells Engrafted into NOD/SCID Mice and Confer Partial Protection against HIV-1 Challenge J. Virol., February 15, 2005; 79(4): 2124 - 2132. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Kambe, H. Hiramatsu, M. Shimonaka, H. Fujino, R. Nishikomori, T. Heike, M. Ito, K. Kobayashi, Y. Ueyama, N. Matsuyoshi, et al. Development of both human connective tissue-type and mucosal-type mast cells in mice from hematopoietic stem cells with identical distribution pattern to human body Blood, February 1, 2004; 103(3): 860 - 867. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. K. Palucka, J. Gatlin, J. P. Blanck, M. W. Melkus, S. Clayton, H. Ueno, E. T. Kraus, P. Cravens, L. Bennett, A. Padgett-Thomas, et al. Human dendritic cell subsets in NOD/SCID mice engrafted with CD34+ hematopoietic progenitors Blood, November 1, 2003; 102(9): 3302 - 3310. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ito, H. Hiramatsu, K. Kobayashi, K. Suzue, M. Kawahata, K. Hioki, Y. Ueyama, Y. Koyanagi, K. Sugamura, K. Tsuji, et al. NOD/SCID/gamma cnull mouse: an excellent recipient mouse model for engraftment of human cells Blood, October 16, 2002; 100(9): 3175 - 3182. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Depraetere, L. Verhoye, G. Leclercq, and G. Leroux-Roels Human B Cell Growth and Differentiation in the Spleen of Immunodeficient Mice J. Immunol., March 1, 2001; 166(5): 2929 - 2936. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. J. Wagar, M. A. Cromwell, L. D. Shultz, B. A. Woda, J. L. Sullivan, R. M. Hesselton, and D. L. Greiner Regulation of Human Cell Engraftment and Development of EBV-Related Lymphoproliferative Disorders in Hu-PBL-scid Mice J. Immunol., July 1, 2000; 165(1): 518 - 527. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. D. Shultz, P. A. Lang, S. W. Christianson, B. Gott, B. Lyons, S. Umeda, E. Leiter, R. Hesselton, E. J. Wagar, J. H. Leif, et al. NOD/LtSz-Rag1null Mice: An Immunodeficient and Radioresistant Model for Engraftment of Human Hematolymphoid Cells, HIV Infection, and Adoptive Transfer of NOD Mouse Diabetogenic T Cells J. Immunol., March 1, 2000; 164(5): 2496 - 2507. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C.M. van der Loo, H. Hanenberg, R. J. Cooper, F.-Y. Luo, E. N. Lazaridis, and D. A. Williams Nonobese Diabetic/Severe Combined Immunodeficiency (NOD/SCID) Mouse as a Model System to Study the Engraftment and Mobilization of Human Peripheral Blood Stem Cells Blood, October 1, 1998; 92(7): 2556 - 2570. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Dazzi, D. Capelli, R. Hasserjian, F. Cotter, M. Corbo, A. Poletti, W. Chinswangwatanakul, J. M. Goldman, and M. Y. Gordon The Kinetics and Extent of Engraftment of Chronic Myelogenous Leukemia Cells in Non-Obese Diabetic/Severe Combined Immunodeficiency Mice Reflect the Phase of the Donor's Disease: An In Vivo Model of Chronic Myelogenous Leukemia Biology Blood, August 15, 1998; 92(4): 1390 - 1396. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. L. Greiner, R. A. Hesselton, and L. D. Shultz SCID Mouse Models of Human Stem Cell Engraftment Stem Cells, May 1, 1998; 16(3): 166 - 177. [Abstract] [Full Text]
|
|
|
|
|
|
M. A. Dao, K. A. Pepper, and J. A. Nolta Long-Term Cytokine Production from Engineered Primary Human Stromal Cells Influences Human Hematopoiesis in an In Vivo Xenograft Model Stem Cells, November 1, 1997; 15(6): 443 - 454. [Abstract] [Full Text]
|
|
|
|
|
|
D. R. Archer, C. W. Turner, A. M. Yeager, and W. H. Fleming Sustained Multilineage Engraftment of Allogeneic Hematopoietic Stem Cells in NOD/SCID Mice After In Utero Transplantation Blood, October 15, 1997; 90(8): 3222 - 3229. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Hogan, E. J. Shpall, O. McNulty, I. McNiece, J. E. Dick, L. D. Shultz, and G. Keller Engraftment and Development of Human CD34+-Enriched Cells From Umbilical Cord Blood in NOD/LtSz-scid/scid Mice Blood, July 1, 1997; 90(1): 85 - 96. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
